Company guide

Corporate philosophy

The healthy function of our body is maintained by systematic differentiation of cells forming tissue and organs according to the plan of gene expression written in our DNA.
However, cancer may form by disordered proliferation of a cell when critical genes are altered by the environment and/or our life habit. The latest statistics estimate that one in two people get cancer, and one in four males and one in six females die of cancer in Japan.
Early-stage cancer may be cured completely by standard therapy under health insurance.
On the other hand, there may be no standard therapy for advanced cancer.
We think that patients have a right to decide whether to take an advanced therapy to live longer while keeping the quality of life. However, it is not easy for patients to decide whether to take advanced therapies due to little information about the treatment.
Therefore, we would like to help cancer patients by researching safe and effective advanced therapies, performing technical cooperation with clinics, and properly advising cancer patients.

CEO Profile

Born in 1964 in Okayama, Japan.
Received Ph.D. based on his studies in Neuroendocrinology at the Graduate School of Biosphere Science, Hiroshima University.
Engaged in research and education at the University of California at Berkeley, Tokyo Medical and Dental University, Waseda University, Monash University Malaysia.
Started to think why cancer forms and if it is possible to cure cancer after his father died of colorectal cancer while studying in the USA.
Joined Gan Medical Service Co., Ltd. in 2020 and started medical consulting of cancer patients. Took office as the CEO of International Cancer Laboratory Co., Ltd. an affiliated company of Gan Medical Service Co., Ltd. in 2022.

Career

March 2005 Awarded Ph.D. from the Graduate School of Biosphere Science, Hiroshima University
2005ー2010年 Postdoctoral Research Fellow of Integrative Biology, the University of California at Berkeley
2010ー2020年 Invited Research Fellow of Waseda Research Institute for Science and Engineering
2010ー2011年 Assistant Professor of Biology, College of Liberal Arts and Sciences, Tokyo Medical and Dental University
2011ー2015年 Lecturer of Biology, College of Liberal Arts and Sciences, Tokyo Medical and Dental University
2015ー2018年 Senior Research Fellow of Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
2019ー2020年 Staff of Eustyle Laboratory
2020ー2022年 Staff of Gan Medical Service
From February 2022 CEO of International Cancer Laboratory

总裁 産贺 崇由

International Cancer Laboratory Co., Ltd.
CEO Takayoshi Ubuka

Staff

Lau Khim Heng

He received his first degree of B.Sc. in Biomedical Sciences at Universiti Kebangsaan Malaysia in 2000 and worked for 5 years at Hematology laboratory as a medical technologist in Singapore General Hospital and National University Hospital of Singapore. In 2005, he obtained his M.Sc. in Biomedical Engineering at Nanyang Technological University Singapore. He further completed the Doctor of Philosophy (D. Phil.) in 2011 at University of Oxford in the UK. His D. Phil. research was about cell imaging of molecular compounds using Secondary Ion Mass Spectrometry (SIMS) on cancer cells and sectioned tumor tissues. He was a lecturer in Monash University Malaysia for about 5 years. His main research interests are in studying different types of cancers, investigating and finding the best treatment methodologies that can cure cancer.

Lau Khim Heng

Overview

Company name International Cancer Laboratory Co., Ltd.
Office address Tokyo, Japan
Foundation date 13 August, 2021
Capital stock 9,000,000 Yen
Description of business 1.Research and development of the prevention, examination, and treatment of cancer
2.Technical cooperation on the prevention, examination, and treatment of cancer
3.International cooperation on the prevention, examination, and treatment of cancer
Adviser Professor of the Graduate School of Integrated Sciences for Life, Hiroshima University
Kazuyoshi Ukena
Business associate Imugene (Australia)
Almac (UK)
Neues (Japan)
Seppic (France)
Bank accounts Mizuho Bank,
The Higashi-Nippon Bank,
Rakuten Bank